Introduction Hepatocellular carcinoma (HCC) carries significant burden of disease, with high
mortality rates and poor prognosis. It is therefore important to consider quality of life (QoL) for …

Purpose Adults with hepatocellular carcinoma (HCC) have a high symptom burden. Their
quality of life (QOL) has been shown to be significantly impacted by both the disease and its …

BACKGROUND & AIMS: This systematic review was conducted to identify the following:(1)
generic and disease-specific measures used to assess health-related quality of life …

Purpose Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related
death worldwide. One of the primary treatment goals for incurable advanced cases is to …

Hepatocellular carcinoma (HCC) is a common and rapidly fatal cancer ranking third among
the leading causes of cancer-related deaths. Potentially curative therapies like surgery …

Purpose Patient-reported outcomes including health-related quality of life (HRQoL) are
important oncological outcome measures. The validation of HRQoL instruments for patients …

Background Prior studies assessing quality of life (QOL) in patients with hepatocellular
carcinoma (HCC) primarily included patients with preserved liver function and/or early HCC …

Health related quality of life (HRQOL) is increasingly recognized as an important clinical
parameter and research endpoint in patients with hepatocellular carcinoma (HCC). HRQOL …

Elevated systemic inflammatory responses, factors associated with physical and mental quality
of life, and prognosis of hepatocellular carcinoma - PMC Back to Top Skip to main content NIH …

Purpose This study aimed to elucidate the patient experience of hepatocellular carcinoma
(HCC) to guide patient-centered outcome measurement in drug development. Methods …